Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04797780
Title Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Syros Pharmaceuticals

myelodysplastic syndrome



Azacitidine + Tamibarotene

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT

No variant requirements are available.